Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 12, 2024 2024-05-20
NOTICE OF ANNUAL GENERAL MEETING 2024-05-20
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES (INCLUDING RESELL OR TRANSFER TREASURY SHARES); (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; (4) PROPOSED AMENDMENTS TO THE POST-IPO SHARE OPTION SCHEME; (5) PROPOSED AMENDMENTS TO THE RESTRICTED SHARE AWARD SCHEME; (6) PROPOSED REFRESHMENT OF THE SCHEME MANDATE LIMIT; AND (7) NOTICE OF ANNUAL GENERAL MEETING 2024-05-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 2024-05-07
2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024-04-29
(1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME 2024-04-23
VOLUNTARY ANNOUNCEMENT – UPDATES ON RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS FOR PRESENTATION AT 2024 AACR ANNUAL MEETING 2024-04-10
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 2024-04-03
(1) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION; AND (2) RENEWAL OF THE MASTER TECHNICAL SERVICE AGREEMENT 2024-04-02
CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE LEASE AGREEMENT 2024-03-28